Ali N, Adil S N, Shaikh M U
Haematology, Department of Pathology and Microbiology, the Aga Khan University, Karachi, Pakistan.
Transpl Infect Dis. 2014 Feb;16(1):98-105. doi: 10.1111/tid.12176. Epub 2014 Jan 3.
Bloodstream infections (BSIs) and central line infections remain among the major causes of morbidity and mortality in transplant recipients because of prolonged neutropenia and mucosal damage. The objective of this study was to determine the frequency and outcome of bacterial and fungal isolates from patients undergoing allogeneic hematopoietic stem cell transplant.
This study was conducted at the Aga Khan University and Hospital's bone marrow transplant unit. All patients who underwent an allogeneic stem cell transplant with matched sibling/parent donor were included. The study period ranged from April 2004 to December 2012. Transplantation was performed according to institutional protocols. All patients were admitted in single rooms with positive pressure and high-efficiency particulate air filters. Ciprofloxacin, fluconazole, and valaciclovir were used for standard prophylaxis, which was started at the time of conditioning. All blood cultures were obtained at clinical suspicion of systemic infection, mainly documented as fever (temperature of >38.5°C). BSIs and line infections were defined as isolation of bacterial or fungal pathogen from at least one blood/central line culture.
In total, 101 of 108 patients developed febrile neutropenia. In the 101 patients, 245 documented febrile episodes occurred. There were 40 culture-positive episodes and 205 culture-negative episodes. Of these 40 culture-positive episodes, 22 patients had bloodstream isolates and 18 had central line isolates. The median ± standard deviation time of febrile neutropenia was day 7 ± 2 days (range: day -3 to day +13). The most common bloodstream isolate was Escherichia coli (n = 9) followed by Staphylococcus epidermidis (n = 5). One patient developed Fusarium infection. In central line infections, S. epidermidis was the most common organism (n = 8). In 2 patients with central venous catheters, Candida albicans was the isolate. Transplant-related mortality from sepsis occurred in 9.2%.
E.coli was mainly responsible for BSI, while gram-positive organisms dominated catheter-related febrile episodes. Transplant-related mortality due to sepsis was 9%.
由于长期中性粒细胞减少和黏膜损伤,血流感染(BSIs)和中心静脉导管相关感染仍然是移植受者发病和死亡的主要原因。本研究的目的是确定接受异基因造血干细胞移植患者的细菌和真菌分离株的频率及结果。
本研究在阿迦汗大学医院的骨髓移植科进行。纳入所有接受与同胞/父母匹配供体的异基因干细胞移植的患者。研究时间段为2004年4月至2012年12月。移植按照机构方案进行。所有患者均入住配备正压和高效空气过滤器的单人病房。环丙沙星、氟康唑和伐昔洛韦用于标准预防,在预处理时开始使用。所有血培养均在临床怀疑有全身感染时采集,主要表现为发热(体温>38.5°C)。血流感染和导管相关感染定义为至少一份血液/中心静脉导管培养物中分离出细菌或真菌病原体。
108例患者中共有101例发生发热性中性粒细胞减少。在这101例患者中,记录到245次发热发作。有40次培养阳性发作和205次培养阴性发作。在这40次培养阳性发作中,22例患者血液中有分离株,18例患者中心静脉导管中有分离株。发热性中性粒细胞减少的中位±标准差时间为第7±2天(范围:-3天至+13天)。最常见的血流分离株是大肠杆菌(n = 9),其次是表皮葡萄球菌(n = 5)。1例患者发生镰刀菌感染。在中心静脉导管相关感染中,表皮葡萄球菌是最常见的病原体(n = 8)。2例中心静脉导管患者的分离株为白色念珠菌。脓毒症导致的移植相关死亡率为9.2%。
大肠杆菌是血流感染的主要原因,而革兰氏阳性菌在导管相关发热发作中占主导地位。脓毒症导致的移植相关死亡率为9%。